C. L. Hello

发表

A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.

C. L. Hello, 2008, Archives of internal medicine.

Macrophagic myofasciitis associated with inclusion body myositis: a report of three cases

J. Viallard, F. Authier, P. Mouton, 2001, Neuromuscular Disorders.

Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC).

A. Carpentier, J. Gris, E. Messas, 2020, Journal de medecine vasculaire.

Lower limb giant cell arteritis and temporal arteritis: followup of 8 cases.

F. Galateau, H. Lévesque, H. Courtois, 2001, The Journal of rheumatology.

[Lower-limb peripheral arterial disease in 2019].

C. Boissier, C. L. Hello, C. Boulon, 2020, La Revue de medecine interne.

Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients.

L. Guillevin, A. Mahr, P. Godmer, 2002, Rheumatology.

Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19

G. Mahé, M. Sprynger, G. Boge, 2020, JMV-Journal de Médecine Vasculaire.

Symptomatic lower-limb giant-cell arteritis: Characteristics, management and long-term outcome.

L. Auboire, M. Barrellier, S. Duthois, 2017, Journal de medecine vasculaire.

Case report Macrophagic myofasciitis associated with inclusion body myositis: a report of three cases

P. Mouton, P. Cherin, S. Herson, 2001 .